US Broker Ratings

Bruker Corporation (BRKR) Stock Analysis: Unveiling a 33% Potential Upside in Healthcare Innovation

Bruker Corporation (NASDAQ: BRKR) stands as a key player in the healthcare sector, carving out a significant niche within the medical devices industry. Based in the United States, this $6.14..

Elanco Animal Health (ELAN) Stock Analysis: Navigating Growth Challenges with Resilient Product Offerings

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a significant player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $7.34..

Globus Medical, Inc. (GMED) Stock Analysis: Unpacking a 51% Potential Upside in the Medical Device Sector

Globus Medical, Inc. (NYSE: GMED), a prominent player in the medical devices industry, has been capturing investor attention with its compelling growth potential and robust product offerings. With a focus..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Exploring a 46% Potential Upside in the Healthcare Sector

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a prominent player in the healthcare sector, has long been a staple in the drug manufacturing industry, particularly in the specialty and generic market...

Vertex Pharmaceuticals (VRTX) Stock Analysis: Exploring Growth Potential Amidst Biotech Innovations

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable player in the biotechnology sector, with a market capitalization of $118.08 billion. Known for its innovative treatments in the realm of..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 30% Upside Potential in the Healthcare Sector

United Therapeutics Corporation (NASDAQ: UTHR) stands out in the healthcare sector with its innovative approaches to treating chronic and life-threatening diseases. This biotechnology company, with a market capitalization of $13.17..

Oscar Health, Inc. (OSCR) Stock Analysis: Exploring a 30% Potential Upside Amid Strong Revenue Growth

Oscar Health, Inc. (NYSE: OSCR) is a noteworthy player in the healthcare plans industry, capturing the attention of investors with its innovative approach and substantial growth prospects. With a market..

Cencora, Inc. (COR) Investor Outlook: A Healthcare Giant with 10.34% Upside Potential

Cencora, Inc. (NYSE: COR), formerly known as AmerisourceBergen Corporation, presents a compelling case for investors with its robust presence in the healthcare sector, specifically within the medical distribution industry. Headquartered..

Integer Holdings Corporation (ITGR) Stock Analysis: Assessing the 32% Upside Potential for Investors

Integer Holdings Corporation (NASDAQ: ITGR), a prominent player in the healthcare sector, is drawing attention from investors due to its robust growth potential and strategic positioning in the medical devices..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Exploring a 27.98% Potential Upside Amidst Market Challenges

Bio-Rad Laboratories, Inc. (NYSE: BIO), a key player in the healthcare sector, is making waves with its promising potential for a 27.98% upside, according to the latest analyst ratings. Despite..

Solventum Corporation (SOLV): Investor Outlook with a 12.12% Potential Upside

Solventum Corporation (SOLV), a burgeoning entity in the healthcare sector, has captured investor attention with its diverse portfolio and potential for growth. With a market capitalization of $12.68 billion, Solventum..

Repligen Corporation (RGEN) Stock Analysis: A 56% Potential Upside Amid Strong Buy Ratings

Repligen Corporation (NASDAQ: RGEN) is garnering significant attention from investors, thanks to its robust presence in the healthcare sector as a leading developer of bioprocessing technologies. With a substantial market..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: A 7.1% Potential Upside in the Healthcare Sector

iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading player in the healthcare sector specializing in digital medical devices, has emerged as a key innovator in the field of ambulatory cardiac monitoring...

Alkermes plc (ALKS) Stock Analysis: A 40% Upside Potential Beckons Investors

Alkermes plc (NASDAQ: ALKS), a prominent player in the specialized pharmaceutical sector, offers a compelling opportunity for investors seeking exposure to the healthcare industry. As a biopharmaceutical company headquartered in..

Hologic, Inc. (HOLX) Stock Analysis: Navigating Growth Challenges with Potential Upside

Investors keen on the healthcare sector might find Hologic, Inc. (HOLX) an intriguing prospect, given its pivotal role in medical instruments and supplies, particularly in women’s health. With a market..

The Ensign Group, Inc. (ENSG) Investor Outlook: A Healthcare Stock with 20% Upside Potential

For investors seeking diversification within the healthcare sector, The Ensign Group, Inc. (NASDAQ: ENSG) offers a compelling opportunity. With a market capitalization of $7.86 billion, The Ensign Group operates within..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 22.59% Potential Upside in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS), a powerhouse in the healthcare sector, specifically within the drug manufacturing industry, is attracting investor attention with a potential upside of 22.59%. This Spanish-based plasma therapeutic..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biopharma with Strong Revenue Growth and Investor Optimism

TG Therapeutics, Inc. (NASDAQ: TGTX) stands out in the biotechnology sector with a notable market capitalization of $6.02 billion. This commercial-stage biopharmaceutical company is making waves with its innovative treatments..

BrightSpring Health Services (BTSG) Investor Outlook: Exploring a Potential 40% Upside

BrightSpring Health Services, Inc. (BTSG) is a noteworthy contender in the Healthcare sector, specifically within the Health Information Services industry. With its roots firmly planted in the United States, the..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a 52.24% Potential Upside Amidst Biotechnology Challenges

Moderna, Inc. (NASDAQ: MRNA), a prominent player in the biotechnology sector, continues to be a focal point for investors, especially with a potential upside of 52.24% based on current analyst..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds